Sara M. B.
- Country
- Spain
- Department
- Urology
Research Overview
- Phase 3 Randomized, Double-blind, Placebo-controlled Study of Apalutamide and Androgen Deprivation Therapy in High-risk Localized or Locally Advanced Prostate Cancer
- Phase 3 Multinational Randomized Study of Sasanlimab with Bacillus Calmette-Guerin in High-Risk Non-Muscle Invasive Bladder Cancer
- Phase 3 Randomized Trial of Intravesical Erdafitinib Delivery System vs. Single-Agent Chemotherapy in FGFR+ Intermediate-Risk Non-Muscle Invasive Bladder Cancer
Data & Insights
Has run more than one trial at 72 of 219 partner sites.
Specializations
Urologic Oncology
The investigator specializes in treating non-muscle-invasive bladder cancer (NMIBC), with particular focus on innovative therapeutic approaches for patients who have not responded to conventional treatments.
- Bladder Cancer Management
- Treatment-Resistant Cases
- Bladder-Preserving Strategies
Their research encompasses therapeutic solutions for patients with carcinoma in situ (CIS) and high-grade papillary disease of the bladder.
Immunotherapy Research
The investigator focuses on advancing immunotherapeutic approaches in urological cancers, particularly exploring combination therapies for enhanced treatment outcomes.
- Novel Immunotherapy Combinations
- Treatment Response Assessment
- Alternative Treatment Pathways
Their work includes evaluation of innovative therapeutic options for patients who are unsuitable for or have declined standard surgical interventions.
Therapeutic Innovation
The investigator specializes in evaluating novel drug delivery systems and combination approaches for treating urological malignancies.
- Local Drug Delivery Systems
- Combination Therapy Approaches
- Treatment Response Monitoring
Their research interests include investigating complete response rates and disease-free survival in various therapeutic combinations.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.